Both compounds require subcutaneous administration for consistent bioavailability
Monotherapy Combination Mounjaro and Jardiance is most appropriate for patients with HbA1c above 8% despite optimized GLP-1 receptor agonist dosing, or those with documented cardiovascular disease, heart failure, or chronic kidney disease who benefit from SGLT2 inhibitor cardio-renal protection
Research peptides are sold for research purposes only, not approved by Health Canada for human consumption
Note changes in energy, digestion, or symptom patterns
The researchers point out that GLP-1RAs are expensive and can potentially widen health disparities as obesity disproportionately affects marginalized racial, ethnic and socioeconomic communities
Mechanistically, a key way MOTS-c influences fat metabolism is through its upstream activation of AMPK and downstream effects on gene expression